Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Post by GoTogetheron Jun 03, 2017 5:31am

191 Views

Post# 26320065

In a few days time: IPA Congress > Dr. Lilge

International Photodynamic Association (“IPA”) World Congress.

Symposium 4 on Friday June 9, 2017 :
"Creating and monitoring a steep PDT-dose gradient for intravesical Non-Muscle Invasive Bladder Cancer " Lothar Lilge (University of Toronto, Canada)

Pavel Kaspler, Ph.D, Theralase, will present, “X-ray and photon mediated in-vitro and in-vivo activity of Ruthenium(II)-based compounds.”

https://www.ipa2017.qui.uc.pt/html/welcome.html

https://www.stockhouse.com/news/press-releases/2017/04/12/theralase-affiliated-researchers-to-present-at-international-conference

EOM.

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario